Jones Trading Assumes Monopar Therapeutics (MNPR) at Buy
Tweet
Share
E-mailGet Alerts MNPR Hot Sheet
Price: $120.21 +0.82%
Rating Summary:
15 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 27 | Down: 45 | New: 5
Rating Summary:
15 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 27 | Down: 45 | New: 5
Join SI Premium – FREE
Jones Trading analyst Boris Peaker assumes coverage on Monopar Therapeutics (NASDAQ: MNPR) with a Buy rating and a price target of $130.00.
For an analyst ratings summary and ratings history on Monopar Therapeutics click here. For more ratings news on Monopar Therapeutics click here.
Shares of Monopar Therapeutics closed at $55.13 yesterday.
You May Also Be Interested In
- Stifel Starts Sutro Biopharma (STRO) at Buy
- JPMorgan Starts Orbbec Inc (688322:CH) at Overweight
- Berenberg Starts OHB SE (OHB:GR) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
